Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ open, 2019 - bmjopen.bmj.com
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, GJ Elder… - 2019 - wslhd.intersearch.com.au
INTRODUCTION: Patients with chronic kidney disease (CKD) are at heightened
cardiovascular risk, which has been associated with abnormalities of bone and mineral …
cardiovascular risk, which has been associated with abnormalities of bone and mineral …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ …, 2019 - search.proquest.com
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ …, 2019 - research.monash.edu
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
[PDF][PDF] Sunil V Badve, 5 Elaine Pascoe, 6, 7 Andrea Valks, 8 Carmel Hawley, 6, 7 on behalf of the IMPROVE-CKD Writing Committee.
N Lioufas, ND Toussaint, E Pedagogos, G Elder - minerva-access.unimelb.edu.au
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
[HTML][HTML] Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ Open, 2019 - ncbi.nlm.nih.gov
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ Open, 2019 - europepmc.org
Patients with chronic kidney disease (CKD) are at heightened cardiovascular risk, which has
been associated with abnormalities of bone and mineral metabolism. A deeper …
been associated with abnormalities of bone and mineral metabolism. A deeper …
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - 2019 - digital.library.adelaide.edu.au
Introduction: Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
[PDF][PDF] Sunil V Badve, 5 Elaine Pascoe, 6, 7 Andrea Valks, 8 Carmel Hawley, 6, 7 on behalf of the IMPROVE-CKD Writing Committee.
N Lioufas, ND Toussaint, E Pedagogos, G Elder - aktn.org.au
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …
risk, which has been associated with abnormalities of bone and mineral metabolism. A …